PCRX (PCRX) Stock Price & Analysis
PCRX (PCRX) fell 0.94% to USD 26.35 as of September 8, 2026 at 06:55 UTC, according to Nexqual real-time market data.
PCRX last closed at USD 26.35; the session ranged USD 26.32–26.65 on volume of 481,690 shares. Market capitalization is —, with a 52-week range of USD 18.8–27.66 (NMS). Source: Nexqual, September 8, 2026 at 06:55 UTC.
Key Statistics (as of September 8, 2026 at 06:55 UTC)
| Price | USD 26.35 |
|---|---|
| Change | ▼ 0.94% (down) |
| Previous Close | USD 26.35 |
| Open | USD 26.35 |
| Day Range | USD 26.32 – 26.65 |
| 52-Week Range | USD 18.8 – 27.66 |
| Volume | 481,690 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (PCRX)
Nexqual's technical model rates PCRX "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 06:55 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 58.73 (neutral) |
| vs SMA50 | Above (USD 25.43) |
| MACD | 0.38 (positive) |
From PCRX's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals, Inc. | USD 43.53 | ▼ 1.14% |
| PTCT | PTC Therapeutics, Inc. | USD 69.3 | ▼ 3.47% |
| IRWD | Ironwood Pharmaceuticals, Inc. | USD 4.26 | ▼ 3.4% |
| COLL | Collegium Pharmaceutical, Inc. | USD 23.53 | ▼ 3.17% |
| ENTA | Enanta Pharmaceuticals, Inc. | USD 14.08 | ▼ 0.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:55 UTC. This page is informational and not investment advice.